Clairol/Pharma Business Exchange Sought By Bristol-Myers

Bristol-Myers Squibb's pending sale of the Clairol hair care brand is likely to involve an assets swap of part or all of a large company's pharmaceutical business, BMS Chairman and CEO Charles Heimbold suggested during an analyst meeting in New York City Sept. 28.